Walgreens Cold Therapy Pain Relief Foot Cream
NDC 0363-1292
Product Information
Walgreens Cold Therapy Pain Relief Foot Cream (menthol) is a OTC MONOGRAPH DRUG-approved product labeled by Walgreen Co.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a cream for topical administration. This product entry covers the primary NDC 0363-1292 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0363-1292?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)
- MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- GLYCERIN (UNII: PDC6A3C0OX)
- .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
- ILEX PARAGUARIENSIS LEAF (UNII: 1Q953B4O4F)
- CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- POLYSORBATE 60 (UNII: CAL22UVI4M)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- GRAPE SEED OIL (UNII: 930MLC8XGG)
- GLUCONOLACTONE (UNII: WQ29KQ9POT)
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
- GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 253020 - menthol 10 % Topical Cream
- RxCUI: 253020 - menthol 100 MG/ML Topical Cream
* Please review the full disclaimer at the bottom of this page.